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Toll-like receptor 6 drives interleukin-17A expression during
experimental hypersensitivity pneumonitis
Introduction
Hypersensitivity pneumonitis (HP) is an interstitial lung
disease caused by repeated inhalation of organic antigens
and low-molecular-weight inorganic particles. Hypersen-
sitivity pneumonitis is an alveolar and interstitial disease;
lung biopsy from an individual with HP is histologically
characterized by poorly formed, non-necrotizing granu-
lomas and interstitial mononuclear cell infiltration.1,2
Sources of the offending antigen are many, and include
bacterial, fungal, animal, or inorganic chemicals (i.e. iso-
cyanates).3,4 Interestingly, despite ubiquitous exposure to
these factors, only 5–15% of exposed individuals ever
develop HP.5 The risk factors of HP are poorly charac-
terized and often require a high index of suspicion to
make a diagnosis. The disease presents in acute, sub-
acute, and chronic forms, depending on the amount
and duration of exposure, as well as individual level of
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Summary
Hypersensitivity pneumonitis (HP) is a T-cell-driven disease that is histo-
logically characterized by diffuse mononuclear cell infiltrates and loosely
formed granulomas in the lungs. We have previously reported that inter-
leukin-17A (IL-17A) contributes to the development of experimental HP,
and that the pattern recognition receptor Toll-like receptor 6 (TLR6)
might be a factor in the initiation of this response. Using a well-established
murine model of Saccharopolyspora rectivirgula-induced HP, we investi-
gated the role of TLR6 in the immunopathogenesis of this disease. In the
absence of TLR6 signalling, mice that received multiple challenges with
S. rectivirgula-antigen (SR-Ag) had significantly less lung inflammation
compared with C57BL/6 mice (wild-type; WT) similarly challenged with
SR-Ag. Flow cytometric analysis of whole lung samples from SR-Ag-chal-
lenged mice showed that TLR6)/) mice had a decreased CD4+ : CD8+
T-cell ratio compared with WT mice. Cytokine analysis at various days
after the final SR-Ag challenge revealed that whole lungs from TLR6)/)
mice contained significantly less IL-17A than lungs from WT mice with
HP. The IL-17A-driving cytokines IL-21 and IL-23 were also expressed at
lower levels in SR-Ag-challenged TLR6)/) mice, when compared with SR-
Ag-challenged WT mice. Other pro-inflammatory cytokines, namely inter-
feron-c and RANTES, were also found to be regulated by TLR6 signalling.
Anti-TLR6 neutralizing antibody treatment of dispersed lung cells signifi-
cantly impaired SR-Ag-induced IL-17A and IL-6 generation. Together,
these results indicate that TLR6 plays a pivotal role in the development
and severity of HP via its role in IL-17A production.
Keywords: hypersensitivity pneumonitis; interleukin-17A; Toll-like
receptor-6
Abbreviations: FITC, fluorescein isothiocyanate; HP, hypersensitivity pneumonitis; IFN, interferon; IL-6, interleukin-6;
PE, phycoerythrin; PRR, pathogen-recognition receptors; RANTES, regulated on activation normal T-cell expressed and secreted;
SR-Ag, Saccharopolyspora rectivirgula-antigen; TGF, transforming growth factor; Th1, T helper type 1; TLR, Toll-like receptor;
WT, wild-type.
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susceptibility, with the chronic form often leading to
fibrotic disease.3,6
Histopathological examination of lung biopsies from
patients with HP have shown B cells, but the exact role of
these lymphocytes in HP pathogenesis has not been inves-
tigated.7,8 Experimental and clinical evidence point
towards a T-cell-mediated mechanism driving HP. For
example, athymic nude mice lacking T cells developed
significantly reduced pathology upon chronic exposure to
HP-inducing Thermoactinomyces vulgaris antigen.9 CD4+
and CD8+ T cells are recruited to the lungs of mice
exposed to Saccharopolyspora rectivirgula antigen (SR-Ag),
with CD4+ T cells predominating.1,10 These CD4+ T cells
are markedly skewed toward a T helper type 1 (Th1) phe-
notype, and it has been shown that Th1-biased C57BL/6
mice are more susceptible to the development of HP,
than are Th2-biased DBA/2 mice.11,12 Increased levels of
inflammatory mediators such as interferon-c (IFN-c),
monocyte chemoattractant protein 1, macrophage inflam-
matory protein 1a, interleukin-6 (IL-6) and IL-12 are also
present in mice after exposure to SR-Ag, and IFN-c (a
Th1-type cytokine) has been shown to be necessary for
the development of HP.13,14 Finally, adoptively transferred
Th1-sensitized CD4+ T cells have the ability to induce HP
in healthy mice, and the overexpression of the Th2 tran-
scription factor GATA-3 is protective against HP.15,16
Taken together, these studies illustrate a critical Th1 com-
ponent in the development of HP.
Many pathologies that were thought to be solely Th1-
mediated, have more recently been shown to require
IL-17A.17–19 Accordingly, we and others have shown that
the gene deletion or in vivo neutralization of IL-17A in
an experimental model of HP driven by repeated SR-Ag
challenges results in protection from HP, indicating that
IL-17A and Th17 cells are also major driving factors.20,21
The IL-17A and Th17 cells drive a pro-inflammatory
immune response by inducing chemokine and chemoattr-
actant production from resident immune and stromal
cells.22 Subsequently, neutrophils and other immune cells
are recruited, thereby intensifying the inflammatory
response.23 Th17 differentiation requires the presence of
IL-6 and transforming growth factor-b (TGF-b), while
expansion and growth of this T-cell population is
regulated by IL-23,24–27 and IL-21 has been shown to be
necessary for induction of Th17 cells.28,29 The exact
signalling mechanisms that lead to Th17 differentiation
during immune responses such as HP are unclear.
It has been shown that recognition of pathogen-associ-
ated molecular patterns by cell-surface receptors called
pathogen-recognition receptors (PRR) is necessary for
activation of host defense mechanisms.30 In our previous
studies, expression of the PRR Toll-like receptor 6
(TLR6), was found to be elevated in experimental HP.20
The TLR6 forms a heterodimer with TLR2 and recognizes
bacterial diacyl lipopeptides and lipoteichoic acid, a major
constituent of Gram-positive bacteria.31 In this study, we
investigated the role of TLR6 in experimental HP, using a
well-established farmer’s lung model, which involves
repeated oropharyngeal challenges of mice with the ther-
mophilic actinomycete S. rectivirgula. Our findings reveal
that IL-17A levels and cytokines associated with the regu-
lation of IL-17A, were significantly reduced in SR-Ag-
challenged mice lacking the TLR6 gene when compared
with similarly challenged wild-type (WT) mice. The
absence of TLR6 resulted in decreased lung inflammation
and protection against HP. Also, neutralization of TLR6
in cultures of dispersed lung cells showed decreased pro-
duction of IL-17A and its regulatory cytokines. Our
observations collectively suggest that TLR6 is essential for
the development of experimental HP, and raise the




Male and female C57BL/6 mice (WT; 6–8 weeks old)
were purchased from Taconic Farms, Inc. (Hudson, NY).
The TLR6)/) mice were generated as previously described
in detail by Takeuchi et al.,32 and were bred at the Uni-
versity of Michigan. All mice were housed under specific
pathogen-free conditions in the University Laboratory
Animal Medicine facility at the University of Michigan
Medical School. The Animal Use Committee at the Uni-
versity of Michigan approved all experiments described
herein.
Saccharapolyspora rectivirgula-induced HP model
Saccharopolyspora rectivirgula (ATCC number 29034) was
purchased from the American Type Culture Collection
(Manassas, VA). The S. rectivirgula antigen (SR-Ag) was
then prepared as previously described by Joshi et al.20 An
oropharyngeal aspiration technique was used to instil
20 lg SR-Ag into the lungs of mice for 3 consecutive days
per week for a total of 3 weeks, as described by Lakatos
et al.33
Quantitative real-time polymerase chain reaction
At days 1, 4, 8 and 16 after the last SR-Ag challenge, right
lung lobes were excised, flash frozen in liquid nitrogen
and stored at ) 80. For isolation of RNA, one right lung
lobe was thawed on ice. TRIzol (Invitrogen Life Technol-
ogies, Carlsbad, CA) was used for RNA extraction accord-
ing to the manufacturer’s instructions. Next, RNA was
converted to complementary DNA using Moloney murine
leukaemia virus reverse transcriptase (Invitrogen). Real-
time quantitative polymerase chain reaction analysis was
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carried out using an ABI PRISM 7700 detection system
(Applied Biosystems, Foster City, CA). Pre-mixed primer/
probe reagents were purchased from Applied Biosystems
to detect TLR6, TLR2, dectin-1, IL-17A, IL-23, IL-21,
IL-6, IFN-c and regulated on activation normal T-cell
expressed and secreted (RANTES) gene expression. Glyc-
eraldehyde 3-phosphate-dehydrogenase was used as an
internal control.
Detection of soluble cytokine and chemokine levels
To determine soluble cytokine and chemokine levels, a
snap-frozen right lung lobe from each mouse was thawed
on ice and homogenized in buffer containing Complete
Mini (Roche Ltd, Basel, Switzerland) protease inhibitor,
and 01% Triton-100. The samples were centrifuged, and
50 ll of cell-free supernatant was analysed using a multi-
plex bead-based assay. IL-13, IL-17A, IFN and RANTES
were detected using Bio-Plex Mouse Grp I 11-plex
cytokine panel from Bio-Rad (Hercules, CA). Enzyme-
linked immunosorbent assay was used to measure IL-6
and TGF-b. The antibodies for the assay were purchased
from R&D Systems (Minneapolis, MN).
Flow cytometry analysis
Whole left lung lobes were excised, minced and digested
with collagenase (Sigma, St Louis, MO) at 37 for 30 min
in a shaker. Erythrocytes were lysed using red blood cell
lysis buffer and the remaining cells were washed and
incubated with anti-CD16/32 to block Fc receptors (eBio-
science, San Diego, CA). The following antibodies were
used to stain the single cell suspensions: fluorescein iso-
thiocyanate (FITC) -conjugated anti-CD4, phycoerythrin
(PE) -conjugated anti-CD3, PECy7-conjugated anti-CD8,
PECy5-conjugated anti-CD45, FITC-conjugated anti-F480
and PE-conjugated anti-CD11c. All conjugated antibodies
were purchased from BD Biosciences (San Jose, CA).
Beckman Coulter FC500 was used to examine the stained
samples and FLOWJO software (Tree Star, Inc., Ashland,
OR) was used to analyse the acquired data.
Histological examination
At days 1, 4, 8 and 16 after the last SR-Ag challenge, the
left lobe from WT and TLR6)/) mice was excised. The
lobe was then inflated with and fixed in 10% formalin.
The fixed lung lobe was embedded in paraffin and 5-lm
sections were then stained with haematoxylin & eosin.
Images were captured using an Olympus BX40 micro-
scope and IP LAB SPECTRUM software (Signal Analytics Corp.,
Vienna, VA). Lung sections were blindly scored following
the method described by Hwang et al.34 At least 100 sec-
tions were examined at 200 · magnification and scored as
follows: 0, no inflammation; 1, < 10% inflammation; 2,
10–30% inflammation; 3, 30–50% inflammation; 4,
50–80% inflammation; 5, > 80% inflammation.
Ex vivo lung culture for antigen restimulation
Lung lobes were excised from mice at days 1, 4, 8 and 16
after the last SR-Ag challenge. A single-cell suspension
was obtained using the collagenase method (described
above). We chose these time-points because they coin-
cided with peak TLR6 (at day 1) and dectin-1 (at day 16)
in WT mice after the last SR-Ag challenge. Approximately
5 · 106 to 8 · 106 cells/ml were cultured in triplicate with
RPMI-1640 supplemented with 10% fetal bovine serum,
100 U/ml penicillin and 100 lg/ml streptomycin in the
presence or absence of 5 lg/ml SR-Ag for 24 hr. Cell-free
supernatants were stored at ) 20 for further analysis by
multiplex bead-based assay. RNA was extracted as previ-
ously described and analysed using real-time quantitative
polymerase chain reaction analysis. One microgram per
millilitre of TLR6 neutralizing antibody (InvivoGen, San
Diego, CA), 1 lg/ml anti-dectin-1 neutralizing antibody
(Hycult biotechnology, Uden, the Netherlands) or 1 lg/
ml normal rat serum isotype control (Jackson Immuno-
Research Laboratories, Inc., West Grove, PA), was added
to other wells to examine the role of these receptors
in vitro.
Statistical analysis
Three to five mice were used per group per time-point in
each experiment. Student’s t-test or one-way analysis of
varaince followed by Student’s Newman–Keuls post test
were used to determine statistical significance. P values
less than 005 were deemed statistically significant. Calcu-
lations were performed using PRISM 4.0 software for Mac-
intosh (GraphPad Software, San Diego, CA).
Results
TLR6 and dectin-1 expression during experimental
hypersensitivity pneumonitis
Changes in whole lung TLR6 transcript expression were
first analysed during the course of experimental HP. A
significant increase in TLR6 transcript expression was
found in the SR-challenged mice at days 1, 4 and 8 after
the last SR-Ag challenge compared with the saline-chal-
lenged control group (Fig. 1a). However, in SR-challenged
mice, TLR6 transcript expression trended lower over time,
with the highest expression observed at day 1 after the
final SR-Ag challenge, and the lowest at day 16 (Fig. 1b).
Because TLR6 forms a heterodimer with TLR2 to mediate
its effects, we also analysed TLR2 transcript expression in
WT and TLR6)/) mice with experimental HP.31 Again,
peak TLR2 transcript expression was observed at day 1
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after SR-Ag challenge and TLR2 expression was lower in
the TLR6)/) mice at days 4, 8 and 16 after SR-Ag com-
pared with the WT group (Fig. 1c). In contrast, dectin-1,
a receptor noted to be involved in IL-17A generation,
showed a significant increase in transcript expression at
day 16 after SR-Ag in WT but not TLR6)/) mice. Den-
dritic cells have been shown to signal through the PRR
dectin-1 to induce Th17 differentiation.35 Together, these
data demonstrate that TLR6 is induced by SR-Ag, but its
expression peaks early after the final SR-Ag challenge
unlike dectin-1, which is induced at a much later time
after the SR-Ag challenges have concluded.
Histopathological examination of TLR6+/+ and
TLR6)/) lungs
The TLR6 appeared to peak at day 1 after SR-Ag so histo-
logical changes in the lungs of SR-challenged mice were
examined at this time. At day 1 after SR-Ag challenge,
lungs from both WT (Fig. 2b,e) and TLR6)/) (Fig. 2c,f)
mice exhibited mononuclear cell infiltration around the
airways and vasculature when compared with lungs from
saline-challenged WT mice (Fig. 2a,d). Overall, lung sec-
tions from SR-Ag-challenged TLR6)/) mice displayed a
reduced inflammatory response. To quantify the differ-
ence in mononuclear cell infiltration, the lung sections
were blindly scored. Significantly greater areas in the
lungs of SR-Ag-challenged TLR6)/) mice were devoid of
inflammatory infiltrate when compared with SR-Ag-
challenged WT mice (Fig. 2g). When analysed as percent-
age of inflamed fields, TLR6)/) lung sections had a
significantly lower percentage of inflamed areas compared
with WT mice at day 1 after SR-Ag challenge (Fig. 2h).
Taken together, these data suggest that the absence of
TLR6 is protective in a murine model of HP, particularly
at the very acute stages after SR-Ag challenge.
Deletion of TLR6 affects lung cellularity
Cell suspensions from whole lung lobes were analysed by
flow cytometry to determine the role of TLR6 in cell
recruitment into the lung during HP. The cells were sub-
sequently counted and the number of cells per mouse was
averaged. At day 1 after SR-Ag challenge, TLR6)/) mice
had significantly fewer lung cells per mouse when com-
pared with SR-Ag-challenged WT mice (Fig. 3a). Previous
studies have shown an increase in the CD4+ : CD8+ ratio
in SR-Ag-induced murine HP.15,36 Using flow cytometry,
we observed that the CD4+ : CD8+ ratio in SR-challenged
TLR6)/) mice was significantly lower when compared
with SR-challenged WT mice at day 1 after SR-Ag chal-
lenge (Fig. 3b). Hence the absence of TLR6 markedly
impacted the recruitment of cells, particularly CD4+
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Figure 1. Pathogen recognition receptor expression in experimental hypersensitivity pneumonitis (HP). Whole lung samples were analysed by
Taqman for gene expression. (a) Transcript expression of Toll-like receptor 6 (TLR6) in whole lungs of wild-type (WT) mice at 1, 4 and 8 days
after their last exposure to Saccharopolyspora rectivirgula antigen (SR-Ag) or saline. Transcript expression for TLR6 (b), TLR2 (c), and Dectin-1
(d), in whole lungs from WT and TLR6)/) mice at 1, 4, 8 and 16 days after final SR-Ag challenge. Results are expressed as fold change over tran-
script expression in WT samples collected at day 1 after the last saline (a), or SR-Ag (b–d) challenge. Data represent the mean ± SEM, with
n = 4 or n = 5 for each group. One-way analysis of variance and Newman–Keuls multiple comparison test were used to analyse significance
between groups. *P  005, ***P  0001.
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Whole lung cytokine transcript and protein levels
from mice with experimental hypersensitivity
pneumonitis
Transcript levels of various cytokines were next analysed
to determine whether TLR6 altered the cytokine profile of
mice exposed to SR-Ag. We and others have recently dis-
covered that IL-17A and its related pathway play a major
role in the immunological response of experimental SR-
Ag-induced HP,20,21 and we first focused on this factor
and its associated cytokines in the present study. As
shown in Fig. 4(a), SR-Ag-challenged TLR6)/) mice
showed decreased IL-17A transcripts at all days and a sig-
nificant decrease at day 16 after the final SR-Ag challenge,
when compared with SR-Ag-challenged WT mice
(Fig. 4a). In SR-Ag-challenged TLR6)/) mice, IL-23 tran-
scripts were lower on days 1 and day 4 after SR-Ag
(Fig. 4b), and IL-21 (Fig. 4c) transcripts were decreased
on day 1, compared with SR-Ag-challenged WT mice.
Both cytokines play major roles in Th17 differentiation;
IL-23 has a key role in the expansion and maintenance of
Th17 cells whereas IL-21 is involved in Th17 differentia-
tion.26,28,29,37,38 Transforming growth factor-b in the pres-
ence of IL-6 has been shown to be necessary for the
generation of Th17 cells.25,27,39 Interleukin-6 transcript
levels from SR-Ag-challenged TLR6)/) mice were
decreased at all time-points, and significantly so on day
16, when compared with SR-Ag-challenged WT mice.
Interestingly, TGF-b transcript expression was not differ-
ent between the groups at any time-point after the last
SR-Ag challenge (not shown). Together, these findings
suggest that IL-17A and Th17-associated cytokines were
decreased in SR-Ag-challenged TLR6)/) mice when com-
pared with SR-Ag-challenged WT mice, suggesting that
this PRR is required for full elaboration of IL-17A, and
related cytokines.
We next examined the soluble cytokine levels from lung
homogenate using a multiplex immunobead assay. The
IL-17A protein levels in SR-Ag-challenged mice were
decreased significantly at day 1 and were lower at day 16,
after the final challenge, when compared with SR-Ag-
challenged WT mice (Fig. 5a). Protein levels of IL-6
peaked at day 8 after the final SR-Ag challenge in whole
lungs from WT mice and levels of this cytokine were not
detected at day 16 in this group (Fig. 5b). In contrast,
levels of IL-6 were constant throughout the time–course
of this SR-Ag HP model in the TLR6)/) groups. These
data suggest that changes in IL-6 levels in the whole lung
depend upon the expression of TLR6.
Previous studies have demonstrated that IFN-c expres-
sion is necessary for the development of the granuloma-
tous inflammatory response in the lungs of mice with











































Figure 2. Histological examination of whole lung samples from wild-type (WT) and Toll-like receptor-6-deficient (TLR6)/)) mice 1 day after the
last Saccharopolyspora rectivirgula antigen (SR-Ag) challenge: magnification, 100 · (a–c), and 200 · (d–f). SR-Ag-challenged lungs from TLR6)/)
mice (c,f) and saline-challenged lungs from WT mice (a,d), show reduced inflammation when compared with SR-Ag-challenged WT lungs (b,e).
Histological scoring of whole lung sections revealed a higher number of fields devoid of inflammatory infiltrate (g) and a lower percentage of
abnormal fields (h) in SR-Ag-challenged TLR6)/) mice when compared with SR-Ag-challenged WT mice. Data shown are mean ± SEM, with
n = 4 or n = 5 for each group. One-way analysis of variance and Newman–Keuls multiple comparison test were used to analyse histological score
significance between groups, and Student’s t-test was used to determine significance between WT and TLR6)/) lungs. *P  005, ***P  0001.
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SR-induced HP.13 Gocke et al.40 have shown that Th1
and Th17 regulation is linked through the transcription
factor T-bet. As shown in Fig. 5(c), IFN-c was
significantly increased at day 4 after SR-Ag challenge in
TLR6)/) mice when compared with WT mice at the same
time after SR-Ag (Fig. 5c). Finally, SR-Ag-challenged
TLR6)/) mice showed increased levels of the Th2 cyto-
kine, IL-13, at day 4, but significantly less IL-13 at day 16
when compared with SR-Ag-challenged WT mice, indicat-
ing that different signalling pathways could be used over
time (Fig. 5d). Together, these data suggest that the
absence of TLR6 has a major effect on the generation of
IL-17A, IL-6, IFN-c, and IL-13 during experimental HP.
TLR6 regulates SR-Ag recall responses in vitro
We next examined the synthetic ability of dispersed lung
cells to generate cytokines after a 24-hr culture with or
without SR-Ag. Transcript expression within the cells and
protein levels in the cell-free culture supernatants were
measured. Dispersed lung cells from SR-Ag-challenged
mice that were restimulated in vitro with SR-Ag showed
significantly elevated levels of IL-17A transcripts on days
1 and 16 when compared with lung cells cultured in med-
ium alone (Fig. 6a). There was no difference in IL-17A
transcript expression between the restimulated TLR6)/)
cells and WT cells harvested from mice 1 day after the
final SR-Ag challenge. However, at day 16 the lung cells
from restimulated TLR6)/) mice showed significantly less
IL-17A transcript levels when compared with lung cells
from restimulated WT cells (Fig. 6a). Interleukin-6 tran-
scripts were increased on day 1 in the dispersed lung cells
that were restimulated with SR-Ag, whereas the lung cells
restimulated with SR-Ag from SR-Ag-challenged TLR6)/)
mice demonstrated a decrease in transcript expression on
day 1 when compared with lung cells from SR-Ag-
challenged WT mice (Fig. 6b). At day 16, SR-Ag restimu-
lation did not result in elevated IL-6 transcript levels over
that from cells cultured in medium alone. The IFN-c
transcript levels were significantly increased at days 1 and
16 in dispersed lung cells restimulated with SR-Ag, when
compared with lung cells cultured in medium alone.
However, TLR6)/) lung cells showed significantly
increased transcript levels when compared with WT lung
cells at day 1, and decreased transcripts compared with
WT lung cells at day 16 (Fig. 6c). It has previously been
shown that the IFN-c-inducible chemotactic factor for
T cells, RANTES, is secreted at elevated levels in patients
and mice with HP.36,41 In our model, RANTES transcript
levels were decreased in lung cells from all SR-Ag-
challenged TLR6)/) mouse groups when compared with
SR-Ag-challenged WT groups (Fig. 6d).
Interleukin-17A protein levels in the cell-free superna-
tants followed similar trends as observed with transcript
levels. The addition of SR-Ag to lung cultures at day 1
after the last in vivo SR-Ag elicited major changes in
IL-17A and IL-6, but not IFN-c or RANTES, in cultures
from WT mice (Fig. 6e,h). The SR-Ag-challenged TLR6)/)
lung cells showed significantly decreased levels of IL-17A
in the SR-Ag-restimulated group at day 16 when
compared with SR-Ag-challenged WT lung cells. Simi-
larly, IL-6 protein levels were also decreased in SR-Ag-
challenged cultures of TLR6)/) cells compared with day
16 SR-Ag-challenged WT lung cells (Fig. 6f). However,
decreased levels of IFN-c were observed in all SR-Ag-
challenged TLR6)/) versus SR-Ag-challenged WT treat-
ment groups (Fig. 6g). Protein levels of RANTES were
also consistent with transcript expression, with decreased
levels measured in all SR-Ag-challenged TLR6)/) lung
cells when compared with SR-Ag-challenged WT lung
cells (Fig. 6h). The TGF-b was analysed, and similar to
the in vivo observations, no significant changes were
observed (not shown). Together, these data highlight that
SR-Ag drives the synthesis of both IL-17A and IL-6, but
not IFN-c or RANTES. Also, the generation of all four














































Figure 3. Role of Toll-like receptor 6 (TLR6) in whole lung cellular-
ity during experimental hypersensitivity pneumonitis (HP). (a) Total
cell count of dispersed whole lung cells from mice at 1 day after the
last Saccharopolyspora rectivirgula antigen (SR-Ag) challenge showed
decreased number of cells from TLR6)/) mice compared with SR-
Ag-challenged wild-type (WT) mice. (b) Flow cytometric analysis of
dispersed lung cells showed a decreased CD4+ : CD8+ ratio in the
lungs of TLR6)/) mice at 4 days after the last SR-Ag antigen chal-
lenge, when compared with SR-Ag-challenged WT mice. Data shown
are mean ± SEM, with n = 4 or n = 5 for each group. Student’s
t-test was used to determine significance between groups *P  005,
***P  0001.
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Neutralization of TLR6 results in decreased
expression of IL-17A and IL-17A-associated cytokines
We next determined the role of TLR6 and dectin-1 in
IL-17A and IL-17A-associated cytokines generated by cul-
tures of lung cells from SR-Ag-challenged WT mice at
day 1 after the last SR-Ag challenge with and without
SR-Ag restimulation, using anti-TLR6 and anti-dectin-1
neutralizing antibodies. Transcript expression for IL-17A,
IL-21, IL-23 and IL-6 was up-regulated in SR-Ag-restimu-
lated lung cells for all groups when compared with lung
cells cultured in medium alone (Fig. 7a–d). The transcript
levels of all four cytokines in the lung cells cultured with
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Figure 4. Interleukin-17A (IL-17A) and IL-17A-associated cytokine transcripts were decreased in Toll-like receptor-6-deficient (TLR6)/)) mice
with experimental hypersensitivity pneumonitis (HP). Cyokine transcript analysis of whole lung samples was performed by Taqman. Transcript
expression of IL-17A (a), IL-23 (b), IL-21 (c) and IL-6 (d), in whole lungs of wild-type (WT) and TLR6)/) mice at 1, 4, 8 and 16 days after the
last Saccharopolyspora rectivirgula antigen (SR-Ag) challenge was determined. Results are expressed as fold change over transcript expression in
WT samples collected at day 1 after the last SR-Ag challenge. Data represent the mean ± SEM, with n = 4 or n = 5 for each group. One-way
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Figure 5. Protein levels in lungs of mice with
experimental hypersensitivity pneumonitis
(HP). Lungs were excised from Toll-like recep-
tor-6-deficient (TLR6)/))and wild-type (WT)
mice at 1, 4, 8 and 16 days after the last Sac-
charopolyspora rectivirgula antigen challenge
and analysed using a multiplex bead-based
assay or enzyme-linked immunosorbent assay.
Interleukin-17A (IL-17A) (a), IL-6 (b), inter-
feron-c (IFN-c) (c) and IL-13 (d) protein lev-
els were measured. Data represent the
mean ± SEM, with n = 4 or n = 5 for each
group. One-way analysis of variance and
Newman–Keuls multiple comparison test
were used to analyse significance between
groups. *P  005.
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down-regulated in comparison with lung cells cultured
with SR-Ag and the isotype antibody control. Similarly,
lung cells treated with the anti-dectin-1 neutralizing anti-
body showed reduced expression of IL-21, IL-23 and IL-6
transcripts (Fig. 7b–d). Interestingly, IL-17 transcript lev-
els were unaffected by anti-dectin-1 treatment (Fig. 7a).
Together, these data highlight the importance of TLR6 in
the generation of IL-17A and its associated cytokines fol-
lowing SR-Ag challenge.
Analysis of protein levels in the cell-free supernatant of
dispersed whole lung cultures revealed elevated levels of
IL-17A, IL-6 and IFN-c in the groups restimulated with
SR-Ag when compared with the medium-alone groups.
Neutralizing TLR6 or dectin-1 in SR-Ag restimulation
cultures resulted in significantly lower levels of IL-17A
and decreased levels of IL-6, compared with isotype con-
trol (Fig. 8a,b). No differences were found in IFN-c pro-































































































































































































































































































































Figure 6. Toll-like receptor 6 (TLR6) regula-
tion of cytokine generation in Saccharopolys-
pora rectivirgula antigen (SR-Ag) -driven recall
responses by dispersed lung cells. At days 1, 4,
8 and 16 days after the final SR-Ag challenge,
dispersed lung cells were cultured for 24 hr
with and without SR-Ag. Cell-free supernatants
were collected for protein analysis and cells
were processed for Taqman analysis. interelu-
kin-17A (IL-17A) (a), IL-6 (b), interferon-c
(IFN-c) (c), and regulated on activation nor-
mal T-cell expressed and secreted (RANTES)
(d) transcript analyses of cell cultures were car-
ried out by Taqman. Results are expressed as
fold change over transcript expression in wild-
type (WT) samples collected at day 1 after the
last SR-Ag challenge. Fifty microlitres of cell-
free supernatant was analysed using a
multiplex bead-based assay or enzyme-linked
immunosorbent assay, to determine protein
levels of IL-17A (e), IL-6 (f), IFN-c (g) and
RANTES (h). Data represent the mean ± SEM,
with n = 3 for each group. One-way analysis
of variance and Newman–Keuls multiple com-
parison test were used to analyse significance
between the WT and TLR6)/) groups.
*P  005, **P  001, ***P  0001.
132 No claim to original US government works. Journal Compilation  2010 Blackwell Publishing Ltd, Immunology, 130, 125–136
D. J. Fong et al.
anti-dectin-1 was insufficient to block IFN-c production
(Fig. 8c). Together, these data showed that activation via
TLR6 was required for the generation of IL-17A and IL-6
during experimental HP.
Discussion
We have previously reported that SR-Ag-induced experi-
mental HP was mediated by IL-17A. While it was clear
that SR-Ag was a potent inducer of IL-17A, it was not
clear which receptor(s) were responsible for this induc-
tion. The present study specifically addressed the role of
TLR6 in the immunopathogenesis associated with SR-Ag-
induced murine HP. This TLR was selected because our
analysis of TLR expression showed that this TLR was
among the most strongly induced TLRs in HP lungs. Fur-
ther impetus for the present study came from an earlier
study by Nance et al.,42 which demonstrated that MyD88,
the adaptor protein for most TLRs, was necessary for SR-
Ag-induced lung inflammation in mice. In the present
study, lung inflammation was significantly reduced in SR-
Ag-challenged TLR6)/) mice when compared with SR-
Ag-challenged WT mice. Analysis of whole lung cytokine
levels revealed that IL-17A was expressed at significantly
lower levels in TLR6)/) mice, again compared with the
WT counterparts. Together, the present findings highlight
the major role of TLR6 in the generation of IL-17A
during SR-Ag-induced HP.
Activation of Th-17-mediated pathways and production
of IL-17A is regulated by cell surface receptors that detect
pathogen-associated molecular patterns and trigger host
responses. The C-type lectin, dectin-1, is a PRR that has
been shown to initiate a pathway promoting an IL-17A
response, particularly in dendritic cells.43 Production of
IL-17A during pulmonary responses to Aspergillus fumiga-
tus in mice is dependent upon dectin-1, and in this con-
text IL-17A has a marked protective effect.19 Our results
suggest that TLR6 might be the major receptor responsi-
ble for the initiation of IL-17A production in SR-induced
murine HP. Analysis of transcript levels from lungs of
TLR)/) mice challenged with SR-Ag consistently demon-
strated decreased transcript levels for IL-17A and IL-17A-
associated cytokines such as IL-6, IL-21 and IL-23. Our
studies on restimulation of ex vivo lung cultures with SR-
Ag show that IL-17, IL-6, IFN-c and RANTES protein
expression was TLR6 dependent in lung cells harvested
from mice at both days 1 and 16 after the last SR-Ag
challenge. Transcript analysis of these factors in these
same cultures showed variable effects of TLR6 deficiency
on transcript expression, particularly for IL-6 and IFN-c.
One explanation for enhanced IFN-c gene expression by
TLR6)/) cells might be the importance of TLR6 signalling
in the translation of IFN-c into protein. Overall, however,
the lack of TLR6 through gene deficiency had a major
effect on the ability of dispersed cells to express IL-17A.
In ex vivo cultures of dispersed lung cells, the addition
of an anti-TLR6 neutralizing antibody resulted in lower
IL-17A and IL-6 levels compared with lung cells treated
with isotype control. Lung cells treated with anti-dectin-1


































   
   
   
   
   


















   
   
   
   
   


















   
   
   
   
   


















   
   
   
   
   








































































































































































Figure 7. Anti-Toll-like receptor 6 (TLR6)
neutralizing antibody reduced interleukin-17A
(IL-17A) and IL-17A-associated transcript lev-
els. At day 1 after the final Saccharopolyspora
rectivirgula antigen (SR-Ag) challenge, dis-
persed lung cells were cultured with and with-
out SR-Ag restimulation. The role of TLR6
and dectin-1 were analysed using anti-TLR6 or
anti-dectin-1 neutralizing antibody. Immuno-
globulin G was used as a control for these
experiments. Results are expressed as fold
change over transcript expression in samples
cultured in medium alone. Cytokine transcript
analysis of IL-17A (a), IL-21 (b), IL-23 (c),
and IL-6 (d) were determined by Taqman.
Data represent the mean ± SEM, with n = 3
for each group.
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transcript levels when compared with isotype control
groups, but protein levels of this cytokine were signifi-
cantly decreased using a similar comparison. These data
suggest that both TLR6 and dectin-1 contribute to IL-17A
production but the difference in the timing of expression
of these receptors could be important for disease initia-
tion and maintenance. It should also be noted that the
expression of dectin-1 was dependent upon TLR6 expres-
sion. Finally, the expression of IL-17A at the intermediate
time-points of days 4 and 8 after SR-Ag appeared to be
independent of TLR6, suggesting that other receptors/
mechanisms contribute to the generation of IL-17A dur-
ing the course of experimental HP. Which additional
innate immune receptors contribute to the immuno-
pathology of HP is currently under investigation in our
laboratory. Taken together, these results suggest that
TLR6 is a critical PRR in recognizing SR-Ag, and that
TLR6–SR-Ag interactions lead to de novo generation of
IL-17A in the lung.
This study also provides some insight into the cross-
regulation between Th17 cells and Th1 cells. It has been
demonstrated that Th1 responses are increased in mice
lacking the IL-17A gene.44 Also, others have shown that
the Th1-mediating transcription factor, T-bet, negatively
regulates IL-17A, providing further evidence of cross-
regulation between Th17 and Th1 responses.45 Consistent
with these reports, in our experimental model, IFN-c in
whole lung was increased in SR-Ag-challenged TLR6)/)
mice, when compared with SR-Ag-challenged WT mice.
Nance et al.14 have shown that IFN-c production from
neutrophils is critical during the immunopathogenesis of
HP. Interestingly, our study shows that an increase in
IFN-c levels in TLR6)/) mice did not result in increased
pathology underscoring the pivotal role of IL-17 in HP
pathogenesis.
In an effort to better understand the role of TLRs in a
clinical setting, various studies have investigated the role
of genetic alterations in disease pathogenesis. Single
nucleotide polymorphisms (SNPs) in TLR genes from
cohort studies have been linked to certain diseases. Rele-
vant to this study, certain loss of function in TLR6 SNPs
have been shown to be associated with a susceptibility to
asthma, an increased risk of non-Hodgkin lymphoma,
and in some cases, increased risk of prostate cancer.46–49
Future studies are required to investigate TLR6 SNPs
because they may play a role in the pathogenesis of HP,
perhaps influencing the susceptibility of a patient to envi-





























































































































































Figure 8. Anti-Toll-like receptor 6 (TLR6) neutralizing antibody
reduced interleukin-17A (IL-17A) and IL-17A-associated cytokine
protein levels. At day 1 after the final Saccharopolyspora rectivirgula
antigen (SR-Ag) challenge, dispersed lung cells were cultured with
and without SR-Ag restimulation. The roles of TLR6 and dectin-1
were analysed by using anti-TLR6 or anti-dectin-1 neutralizing anti-
body. Immunoglobulin G was used as a control for these experi-
ments. IL-17A (a), IL-6 (b), and interferion-c (IFN-c) (c) protein
levels were measured using a multiplex bead-based assay or enzyme-
linked immunosorbent assay. Data represent the mean ± SEM, with
n = 3 for each group. One-way analysis of variance and Newman–
Keuls multiple comparison test were used to analyse significance
between groups. *P  005.
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In summary, the present study demonstrates that the
deletion of TLR6 in experimental HP significantly
impairs IL-17A generation and markedly reduces disease
severity. Moreover, neutralization of TLR6 in ex vivo
lung cultures results in reduced transcript and protein
levels of IL-17A and IL-17A-associated genes. Recently,
it has been reported that IL-17A plays a protective role
in a model of HP that involves repeated exposure to live
Bacillus subtilis.50 Further studies are required to address
the role of TLR6 in this model. In conclusion, we report
a critical role for TLR6 in the development of HP, and
also suggest that this might be a therapeutic target in
clinical HP.
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